Jiro Usuki
Tokyo, 1138603, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis.
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis.
Journal: Experimental cell research
Published: December 13, 2019
Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: November 29, 2019
Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
Journal: Respiratory research
Published: October 04, 2017
XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts.
Journal: Pulmonary pharmacology & therapeutics
Published: December 29, 2016
Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: December 20, 2014
Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
Journal: Pulmonary pharmacology & therapeutics
Published: November 10, 2014
Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Journal: Internal medicine (Tokyo, Japan)
Published: November 06, 2012
Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: March 09, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026